Corporate Profile for Biopool International Inc., dated Aug. 29, 1997.

--(BUSINESS WIRE)--The following Corporate Profile is available for inclusion in your files. News releases for this client are distributed by Business Wire and also become part of the leading databases and online services, including all of the leading Internet-based services. -0-

  Published Date:   Aug. 29, 1997  Company Name:     Biopool International Inc.  Address:          6025 Nicolle St.                   Ventura, Calif. 93003  Main Telephone  Number:          805/654-0643  Chief Executive  Officer:         Michael D. Bick  Chief Financial  Officer:         Robert K. Foote  Trading Symbol/  Exchange:        BIPL (Nasdaq)  Industry:         Medical devices  Market Makers:    Mayer & Schweitzer, Knight Securities, Nash                   Weiss, Herzog Heine Geduld, Wien Securities,                   Sherwood Secs., M.H. Meyerson & Co., Wilson-Davis                   & Co., Troster Singer Corp., Rocky Mountain Secs.  Company description:  Biopool International Inc. develops, manufactures and markets a full range of in vitro diagnostic blood test kits used to assess and diagnose disorders of blood coagulation, thrombotic risk factors, fibrinolysis, platelet function and the vascular system.  The company also provides specialty chemistry controls used to monitor and measure the presence of drugs of abuse and immunohematology products used in routine ABO and Rh blood grouping and to screen for rare antibodies and antigens in blood.  Incorporated in Delaware in 1987 and with headquarters in Ventura, Calif., Biopool has two subsidiaries, Biopool AB (Sweden) and Biopool Canada, and a newly acquired division, BCA, located in West Chester, Pa.  The acquisition of this division from Organon Teknika Corp. in January 1997 effectively doubled the size of the company.  Biopool's complete line of more than 150 FDA-approved products is sold to hospitals, clinical laboratories, commercial reference laboratories, blood centers and biomedical research institutions on a worldwide basis.  In addition to selling its products through distributors in more than 40 countries, Biopool also develops and manufactures test kits under private label and OEM agreements with such companies as Dade International, Instrumentation Laboratory, Ortho Diagnostic Systems (a division of Johnson & Johnson) and Sigma Diagnostics (Sigma/Aldrich).   STOCK DATA:  Symbol:                 BIPL FYE:                    12/31 52-Week High/Low        $3.81 - $1.93 30-Day Avg. Daily   Vol. (a) :            27,000 Float:                  $5.1 million (approx.) Shares Outstanding:     8,621,248 Market Cap (a) :        $19.4 million  (a)  Aug. 25, 1997.   STATEMENT OF INCOME  (in thousands, except per-share data)  For Years Ended Dec. 31,      1996      1995     1994  Sales                        $8,020    $6,662   $5,527 Income before taxes           1,180       261      816 Net income                    1,295       141      705 Earnings per share           $  .15    $  .02   $  .09  

CONTACT: Bipool International Inc.